The ILPMPAC is authorized to have a standing subcommittee. This
subcommittee shall be a ten-member Peer Review Committee. The Peer Review
Committee shall advise the ILPMP on matters relating to the advisory
committee's field of competence, establish a formal peer review of the
professional performance of prescribers and dispensers, and develop
communications to transmit to prescribers and dispensers. The deliberations,
information, and communications of the Peer Review Committee are privileged and
confidential and shall not be disclosed in any manner except in accordance with
current law.
a) The ILPMPAC shall
select 10 of its members to be part of the Peer Review Committee.
b) The Peer Review Committee shall consist of
the following:
1) three physicians;
2) three pharmacists;
3) one dentist;
4) one advanced practice registered
nurse;
5) one physician assistant;
and
6) one optometrist.
c) The Peer Review Committee shall
meet, at a minimum, semi-annually.
d) The Peer Review Committee shall
periodically review the data contained within the ILPMP database to identify
those prescribers or dispensers who may be prescribing or dispensing outside
the currently established professional standards for the prescriber's or
dispenser's field of practice and for the type of medication (e.g., opioids) or
type of care (e.g., hospice) applicable to the prescription under review. The
Peer Review Committee member(s), whose profession is the same as the prescriber
or dispenser being reviewed, shall make recommendations for any non-action or
action. The ILPMP Clinical Director and staff shall provide necessary
assistance and data as required. [720 ILCS
570/320(f)(1) ]
e) The Peer Review Committee may request
information regarding the prescribing or dispensing practices of identified
providers. Requests for information shall be sent via certified mail. A
prescriber or dispenser shall have 30 days to respond to the request for
information. [720 ILCS
570/320(f)(2) ]
f) Pursuant to
720 ILCS
570/320(f)(3), the Peer Review
Committee shall refer a prescriber or dispenser to DFPR:
1) if a prescriber or dispenser does not
respond to three successive requests for information;
2) if, in the opinion of a majority of the
members of the Peer Review Committee, the prescriber or dispenser does not have
a satisfactory explanation for the practices identified by the Peer Review
Committee or the prescriber or dispenser does not have a satisfactory
explanation for the practices identified by the Peer Review Committee in its
request for information; or
3) if,
following communications with the Peer Review Committee, the prescriber or
dispenser does not sufficiently rectify the practices identified in the request
for information in the opinion of a majority of the members present of the Peer
Review Committee.
g) The
Peer Review Committee shall prepare an annual report to the General Assembly
starting on July 1, 2017. Pursuant to
720 ILCS
570/320(5), the annual report shall
be delivered electronically to the Department and to the General Assembly. The
report to the General Assembly shall be filed with the Clerk of the House of
Representatives and the Secretary of the Senate in electronic form only, in the
manner that the Clerk and the Secretary shall direct. The report shall contain
the following information:
1) the number of
times the Peer Review Committee was convened;
2) the number of prescribers or dispensers
who were reviewed by the Peer Review Committee;
3) the number of requests for information
sent out by the Peer Review Committee; and
4) the number of prescribers or dispensers
referred to DFPR.
